Search tips
Search criteria 


Logo of brheartjLink to Publisher's site
Br Heart J. 1959 July; 21(3): 315–322.
PMCID: PMC1017586


Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BALATRE P, MERLEN J, GRANDJEAN L. Les esters nitrés des polyalcools en thérapeutique cardiovasculaire. Presse Med. 1949 Nov 19;57(73):1067–1069. [PubMed]
  • CESARMAN T. Serendipitia y angina de pecho; informe priliminar sobre un hallazgo terapeutico. Arch Inst Cardiol Mex. 1957 Sep-Oct;27(5):563–580. [PubMed]
  • COLE SL, KAYE H, GRIFFITH GC. Assay of anti-anginal agents. I. A curve analysis with multiple control periods. Circulation. 1957 Mar;15(3):405–413. [PubMed]
  • COSSIO P. The treatment of angina pectoris and other muscular pain due to ischemia with iproniazid and isoniazid. Am Heart J. 1958 Jul;56(1):113–118. [PubMed]
  • FIFE R, HOWITT G, STEVENSON J. Trial of drugs for angina of effort: the oral use of pentaerythritol tetranitrate, including a comparison with aminophylline and dihydroxypropyltheophylline. Scott Med J. 1958 Jan;3(1):15–20. [PubMed]
  • GREINER T, GOLD H, CATTELL M, TRAVELL J, BAKST H, RINZLER SH, BENJAMIN ZH, WARSHAW LJ, BOBB AL, KWIT NT, et al. A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin). Am J Med. 1950 Aug;9(2):143–155. [PubMed]
  • JANUARY LE, LEWIS BI, LUBIN RI, WILD JB. Rauwolfia serpentina in the treatment of angina pectoris. Circulation. 1956 Aug;14(2):227–232. [PubMed]
  • PERLMAN A. A study of the therapeutic action and toxicity of pentaerythritol tetranitrate. Angiology. 1952 Feb;3(1):16–19. [PubMed]
  • PLOTZ M. Pentaerythritol tetranitrate: a new drug for the treatment of coronary insufficiency. N Y State J Med. 1952 Aug 15;52(16):2012–2015. [PubMed]
  • RISEMAN JE, ALTMAN GE, KORETSKY S. Nitroglycerin and other nitrites in the treatment of angina pectoris; comparison of six preparations and four routes of administration. Circulation. 1958 Jan;17(1):22–39. [PubMed]
  • ROSENBERG HN, MICHELSON AL. The use of pentaerythritol tetranitrate in chronic coronary insufficiency. Am J Med Sci. 1955 Sep;230(3):254–258. [PubMed]
  • RUSSEK HI, ZOHMAN BL, DORSET VJ. Objective evaluation of coronary vasodilator drugs. Am J Med Sci. 1955 Jan;229(1):46–54. [PubMed]
  • RUSSEK HI, ZOHMAN BL, DRUMM AE, WEINGARTEN W, DORSET VJ. Long-acting coronary vasodilator drugs: metamine, paveril, nitroglyn and peritrate. Circulation. 1955 Aug;12(2):169–175. [PubMed]
  • SILBER EN, KATZ LN. Coronary dilators and angina: reappraisal. J Am Med Assoc. 1953 Nov 21;153(12):1075–1076. [PubMed]
  • TALLEY RW, BEARD OW, DOHERTY JF. Use of pentaerythritol tetranitrate (peritrate) in treatment of angina pectoris. Am Heart J. 1952 Dec;44(6):866–871. [PubMed]
  • WEITZMAN D. Penta-erythritol tetranitrate in treatment of angina. Br Med J. 1953 Dec 26;2(4851):1409–1412. [PMC free article] [PubMed]
  • WINSOR T, HUMPHREYS P. Influence of pentaerythritol tetranitrate (peritrate) on acute and chronic coronary insufficiency. Angiology. 1952 Feb;3(1):1–15. [PubMed]
  • WINSOR T, SCOTT CC. Further observations of cardiovascular effects of pentaerythritol tetranitrate in animals and man. Am Heart J. 1955 Mar;49(3):414–427. [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group